Artículo o Paper
Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation
Fecha
2021-06-08Registro en:
Cabaña-Brunod, M., Herrera, P. A., Márquez-Miranda, V., Llancalahuen, F. M., Duarte, Y., González-Nilo, D., ... & Otero, C. (2021). Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation. Drug Delivery, 28(1), 1020-1030.
1071-7544
eISSN 1521-0464
WOS: 000656903500001
PMID: 34060399
10.1080/10717544.2021.1923862
Autor
Cabaña-Brunod, Mauricio
Herrera, Pablo A.
Llancalahuen, Felipe M.
Duarte, Yorley
Gonzalez-Nilo, Danilo
Fuentes, Juan A.
Vilos, Cristian
Velásquez, Luis
Otero, Carolina
Marquez-Miranda, Valeria [Univ Mayor, Fac Sci, Ctr Appl Nanotechnol, Chile]
Institución
Resumen
NOD1 is an intracellular receptor that, when activated, induces gene expression of pro-inflammatory factors promoting macrophages and neutrophils recruitment at the infection site. However, iE-DAP, the dipeptide agonist that promotes this receptor's activation, cannot permeate cell membranes. To develop a nanocarrier capable of achieving a high and prolonged activation over time, iE-DAP was encapsulated in nanoparticles (NPs) made of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV). The physicochemical properties, colloidal stability, encapsulation efficiency, and cellular uptake of iE-DAP-loaded PHVB NPs were analyzed. Results evidenced that physicochemical properties of iE-DAP-loaded NPs remained stable over time, and NPs were efficiently internalized into cells, a process that depends on time and concentration. Moreover, our results showed that NPs elicited a controlled cargo release in vitro, and the encapsulated agonist response was higher than its free form, suggesting the possibility of activating intracellular receptors triggering an immune response through the release of NOD1 agonist.